Egidijus Bacevicius

Egidijus Bacevicius is a Lecturer at Aalborg University Hospital’s Department of Clinical Medicine under The Faculty of Medicine. His work focuses on nephrology, particularly in kidney disease treatment and clinical trials involving hemodialysis patients. He has contributed to studies comparing paricalcitol and alfacalcidol in managing secondary hyperparathyroidism.

His research interests include endocrine disorders related to renal dysfunction, clinical pharmacology, and bone metabolism in chronic kidney disease patients. He has actively participated in major conferences such as the ISN World Congress of Nephrology (2013), American Transplant Congress (2013), and the International Society for Peritoneal Dialysis Congress (2012).

Bacevicius presented his team’s randomized crossover trial findings at the ASN Renal Week 2011. While no specific labs or teams are explicitly mentioned, his collaborative work spans nephrology and clinical medicine departments at Aalborg University Hospital.